Kidney Stones Clinical Trials

Find Kidney Stones Clinical Trials Near You

Modified Mini Percutaneous Nephrolithotomy Versus Standard Percutaneous Nephrolithotomy for the Treatment of Complex Renal Calculi: A Multicenter Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Kidney stones that are large or complex are often treated with percutaneous nephrolithotomy, also called PCNL. Standard PCNL uses a larger access tract and is effective for removing complex kidney stones, but it may be associated with more bleeding, pain, and recovery burden. Modified mini-PCNL uses a smaller access tract and may reduce surgical trauma while maintaining a similar stone clearance rate. This multicenter randomized trial will compare modified mini-PCNL using a 20 Fr access sheath with standard PCNL using a 24 Fr access sheath in adults with complex renal stones. About 1,380 participants from 8 urology centers will be randomly assigned to receive one of the two procedures. The main purpose of the study is to determine whether modified mini-PCNL is not worse than standard PCNL in achieving stone-free status shortly after surgery. Stone-free status will be assessed by low-dose noncontrast CT within 72 hours after surgery. The study will also compare stone-free status at 3 months, complications, operation time, length of hospital stay, need for additional procedures, and quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Adults aged ≥18 years.

• Serum creatinine ≤133 μmol/L.

• American Society of Anesthesiologists (ASA) physical status classification I-III.

• S.T.O.N.E. score ≥8.

• Complex renal stones confirmed by noncontrast computed tomography, including stone surface area \>1500 mm², multiple calyceal stones, partial or complete staghorn calculi, or complex anatomical conditions.

• Patients who provide written informed consent and agree to undergo either modified mini-percutaneous nephrolithotomy or standard percutaneous nephrolithotomy.

Locations
Other Locations
China
The First Affiliated Hospital of Guangzhou Medical University
RECRUITING
Guangzhou
Contact Information
Primary
Yongda Liu, Doctor
13719007083@163.com
+020-83062923
Time Frame
Start Date: 2026-07-15
Estimated Completion Date: 2027-09-14
Participants
Target number of participants: 1380
Treatments
Experimental: Modified Mini-PCNL
Participants randomized to this arm will undergo 20 Fr modified mini percutaneous nephrolithotomy using the F17 Hawk nephroscope for the treatment of complex renal stones.
Active_comparator: Standard PCNL
Participants randomized to this arm will undergo 24 Fr standard percutaneous nephrolithotomy using the F20.8 Wolf nephroscope for the treatment of complex renal stones.
Related Therapeutic Areas
Sponsors
Leads: The First Affiliated Hospital of Guangzhou Medical University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials